Researchers at UC San Diego have found that palbociclib, a breast cancer drug, shows promise for treating a rare form of appendix cancer called peritoneal mucinous carcinomatosis (PMC). Dr. Andrew Lowy, co-senior author and ACPMP Medical Advisory Board Member, says, "Finding that a breast cancer drug is successful in treating a subset of appendix cancer — where treatment options are...

Thank You for a Remarkable Appendix Cancer Awareness Month! As we wrap up Appendix Cancer Awareness Month, we want to take a moment to express our heartfelt gratitude to our volunteers, supporters, and community. This month has been a resounding success, and it wouldn't have been possible without their unwavering support and dedication. To our volunteers - your tireless efforts,...

We are thrilled to announce that ACPMP is funding a significant new $100,000 grant this year: The Lisa Kurtz Luciano Appendix Cancer and Pseudomyxoma Peritonei Clinical Investigator Award! Thanks to all of our supporters and their donations, ACPMP is pleased to be able to fund this Society of Surgical Oncology (SSO) award focused solely on appendix cancer and PMP. Named...

Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation Announces the Lighting of Landmarks to raise awareness for Appendix Cancer Awareness Month. BOSTON, MA, USA, July 31, 2024 /EINPresswire.com/ -- ACPMP is proud to announce the launch of Appendiceal Cancer Awareness Month this August. In an effort to bring attention to this rare but critical disease, iconic buildings and landmarks across the...

The Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation is pleased to welcome Dr. John Paul Shen to our Medical Advisory Board. Dr. Shen has been a long-time contributor to ACPMP, and to moving appendiceal cancer research forward. Dr. Shen is an Assistant Professor in the Department of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center with...

The Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation, a national non-profit dedicated to funding research and education, and raising awareness of appendix cancer and Pseudomyxoma Peritonei (PMP), is pleased to announce the lighting of landmarks nationwide in August in support of Appendix Cancer Awareness Month. This initiative, aptly named “Light Up Amber for Appendix Cancer”, will see landmarks and buildings...

August is recognized as the official Appendix Cancer Awareness Month to increase awareness of this rare cancer and the need for MORE research to discover new treatments with the hope of one day finding a cure. The ACPMP Research Foundation was established in 2008 to fund research and education to improve the diagnosis and treatment of appendix cancer. Along with...

The Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation is pleased to announce the recipients of our 2021 research grant cycle. Thank you as always to our incredible, dedicated supporters, fundraisers, and donors for making these grants happen. And thank you to the many researchers who applied to our research grant program and to all of the scientific community engaged in...

              Congratulations to Dr. John Paul Shen at MD Anderson for being a recipient of the 2022 ASCO Conquer Cancer Foundation Career Development Award (CDA). This CDA comes with a 3-year, $200,000 research grant focused on appendix cancer. The ACPMP Research Foundation is pleased to have previously provided Dr. Shen with a letter of...

This week is Adolescent and Young Adult (AYA) Cancer Awareness week, April 4th - April 8th. Adolescent and Young Adult Cancer Awareness Week was created to help shine a light on the unique challenges that AYA cancer survivors face each day. The Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation would like to share some facts and resources to educate and...